Table 3

Cumulative rates of MACE

Variables30 Days6 Months12 Months
No. of patients, n995986980
Death, n (%)7 (0.7)10 (1.0)22 (2.2)
 Cardiac death, n (%)7 (0.7)9 (0.9)18 (1.8)
 Non-cardiac death, n (%)0 (0)1 (0.1)4 (0.4)
MI, n (%)4 (0.4)15 (1.5)16 (1.6)
TLR, n (%)0 (0)5 (0.5)7 (0.7)
Non-TL TVR, n (%)0 (0)0 (0)2 (0.2)
Overall stent thrombosis, n (%)0 (0)11 (1.1)11 (1.1)
 Definite stent thrombosis, n (%)0 (0)3 (0.3)3 (0.3)
 Probable stent thrombosis, n (%)0 (0)8 (0.8)8 (0.8)
 Possible stent thrombosis, n (%)0 (0)0 (0)0 (0)
MACE, n (%)11 (1.1)22 (2.2)36 (3.7)
  • MACE, major adverse cardiac events; MI, myocardial infarction; non-TL TVR, non-target lesion target vessel revascularization; TLR, target lesion revascularization.